Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get FeederClinical trials RSS feeds
The Clinical trials RSS feeds Feeder users follow most, including News and press releases, Nature Medicine - Issue - nature.com science feeds and Agendas and minutes. Copy a feed URL or follow them free in Feeder.
Related topics
Health RSS feeds Medical research RSS feeds Mental health RSS feeds Psychology RSS feeds Public health RSS feeds Pharma RSS feeds Oncology RSS feeds
Suggest an editNature Medicine - Issue - nature.com science feeds
Original research articles published in Nature Medicine range from basic findings that have clear implications for disease pathogenesis and therapy to the earliest phases of human investigation. Aiming to keep Ph.D. and M.D. readers informed of a wide range of biomedical research findings, the journal publishes the latest advances in cancer biology, vascular biology, neuroscience, inflammatory disease, infectious disease and metabolic disorders, among other fields. Reviews, Perspectives and other commissioned content clarify and give context to these biomedical research advances, and the News section reports on the latest developments in drug research and development.
Health Canada RSS - Drug Products, Drugs and Health Products
Stay informed when new items, such as guidance documents, Summary Basis of Decisions for Drug Products, updates to the Registers of Innovative Drugs, policies and forms, are added to the Drug Products section of the website.
Nature Medicine
Original research articles published in Nature Medicine range from basic findings that have clear implications for disease pathogenesis and therapy to the earliest phases of human investigation. Aiming to keep Ph.D. and M.D. readers informed of a wide range of biomedical research findings, the journal publishes the latest advances in cancer biology, vascular biology, neuroscience, inflammatory disease, infectious disease and metabolic disorders, among other fields. Reviews, Perspectives and other commissioned content clarify and give context to these biomedical research advances, and the News section reports on the latest developments in drug research and development.
Retraction Watch
Tracking retractions as a window into the scientific process
Massachusetts Medical Society: New England Journal of Medicine: Table of Contents
Table of Contents for New England Journal of Medicine. List of articles from both the latest and ahead of print issues.
ClinicalTrials.gov: ovarian | Not yet recruiting, Recruiting studies | Phase: 2, 3 | Interventional studies | Study start on or after 01/01/2023 | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: ovarian | Not yet recruiting, Recruiting studies | Phase: 2, 3 | Interventional studies | Study start on or after 01/01/2023 | First posted in the last 14 days
Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat]
Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat]: Latest results from PubMed
ClinicalTrials.gov: Ovarian Cancer | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Ovarian Cancer | Last update posted in the last 14 days
Nature Reviews Drug Discovery
Nature Reviews Drug Discovery integrates academia and industry, providing broad, expert coverage of the whole drug discovery and development arena – from disease mechanisms, novel therapeutic approaches and chemistry to clinical trials and regulatory affairs. All reviews are carefully commissioned, written by leaders in the field and subject to rigorous peer-review so that readers receive independent, high-quality and authoritative articles in each issue. Reviews are complemented by news stories that investigate the key issues in drug discovery, timely summaries of significant published papers, market analysis, and updates on the latest advances in fast-moving areas such as new technologies, drug approvals and patent law. Information is presented at several levels that can be tailored to users’ individual needs. Non-specialists will benefit from the glossary and highlighted references, and experts will appreciate the insight provided by top names in their field. Nature Revi
ClinicalTrials.gov: Gardasil | Last update posted in the last 2 days
Studies found on ClinicalTrials.gov by a search of: Gardasil | Last update posted in the last 2 days
ClinicalTrials.gov: cervarix | Last update posted in the last 2 days
Studies found on ClinicalTrials.gov by a search of: cervarix | Last update posted in the last 2 days
TGA - Resources
Search our resources for guidance, checklists, international scientific guidelines, compositional guidelines and forms.
Business Wire - News by Company: AstraZeneca
Business Wire - The global leader in news distribution
ASCO: Journal of Clinical Oncology: Table of Contents
Table of Contents for Journal of Clinical Oncology. List of articles from both the latest and ahead of print issues.
GlobeNewswire - Industry News on Biotechnology
Contains the last 20 releases
Endpoints News
Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
TGA latest news and updates
Read our latest news on regulatory decisions and activities, including product safety and enforcement actions.
PharmaTimes: News RSS
in-depth news, features and insights for the pharmaceutical and healthcare sectors
Business Wire Health: Clinical Trials News
Health: Clinical Trials News Distributed by Business Wire
The New England Journal of Medicine: Search Results in Cardiology
The New England Journal of Medicine (NEJM) RSS feed -- Search Results in Cardiology. NEJM (https://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.